Found 145 matching trials
Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer
PHASE1This clinical trial will be conducted as a single-center, open-label, Phase...
Location
University of Iowa Hospitals and Clinics
Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer
PHASE1This is a randomized, open, comparative, multi-centre study which will recr...
Location
Institut Ste Catherine
Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab
PHASE1The goal of this Phase 1b clinical trial is to evaluate the safety and effi...
Status
Active Not Recruiting
Location
University of California, San Diego
Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC
PHASE1This is an open-label, multicenter, 2-arm study to evaluate the safety and ...
Location
Research Facility
Durvalumab and Lenvatinib in Participants With Advanced and Recurrent Endometrial Carcinoma
NAThis study will evaluate the safety and efficacy of durvalumab in combinati...
Location
Multiple Locations
A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer
PHASE1This study is designed to determine the efficacy and safety of durvalumab i...
Status
Active Not Recruiting
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
PHASE1The investigators propose to evaluate the safety of drug combinations in pa...
Location
University of Kansas Cancer Center
JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
PHASE1This phase Ib trial studies whether anti-CD19-chimeric antigen receptor (CA...
Location
Fred Hutch/University of Washington Cancer Consortium
Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Resectable Esophageal Squamous Cell Carcinoma
PHASE2This is a study to evaluate the efficacy and safety of preoperative treatme...
Location
Peking Union Medical College Hospital
TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer
PHASE2This is a Phase 2 clinical trial, which tests two investigational drugs: TP...
Location
Memorial Sloan Kettering Cancer Center at Basking Ridge